- By insider

CEO of Odonate Therapeutics Inc (ODT) Kevin C Tang bought 14,050 shares of ODT on 03/01/2018 at an average price of $27.42 a share. The total cost of this purchase was $385,251.

Odonate Therapeutics Inc is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer. Odonate Therapeutics Inc has a market cap of $743.670 million; its shares were traded at around $27.21 .

• Warning! GuruFocus has detected 2 Warning Sign with ODT. Click here to check it out.

• ODT 15-Year Financial Data

• The intrinsic value of ODT

• Peter Lynch Chart of ODT

CEO Recent Trades:

• CEO, 10% Owner Kevin C Tang bought 14,050 shares of ODT stock on 03/01/2018 at the average price of $27.42. The price of the stock has decreased by 0.77% since.

• CEO, 10% Owner Kevin C Tang bought 28,612 shares of ODT stock on 02/27/2018 at the average price of $27.42. The price of the stock has decreased by 0.77% since.

• CEO, 10% Owner Kevin C Tang bought 39,083 shares of ODT stock on 02/22/2018 at the average price of $27.17. The price of the stock has increased by 0.15% since.

• CEO, 10% Owner Kevin C Tang bought 128,255 shares of ODT stock on 02/16/2018 at the average price of $22.47. The price of the stock has increased by 21.09% since.

For the complete insider trading history of ODT, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 2 Warning Sign with ODT. Click here to check it out.

• ODT 15-Year Financial Data

• The intrinsic value of ODT

• Peter Lynch Chart of ODT